ATM in lymphoid development and tumorigenesis

Advances in Immunology

Volumn , Issue 72, 1999, Pages 179-189

  Yang, X U ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; T LYMPHOCYTE RECEPTOR;

ATAXIA TELANGIECTASIA; CARCINOGENESIS; DNA RECOMBINATION; DNA STRAND BREAKAGE; GENE MUTATION; HUMAN; LEUKEMIA; LYMPHOMA; LYMPHOPOIESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE RECEPTOR GENE;

EID: 0033500811     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (58)

1. Alt, F. W., Black-well, T. K., and Yancopoulos, G. D. (1987). Development of the primary antibody repertoire. Science 238, 1079-1087.
2. Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J. N., Ried, T., Tagle, D., and Wynsliaw-Boris, A. (1996). Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 86, 159-171.
3. Baskaran, B., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M. B., and Wang, J. Y. (1997). Ataxia telangiectasia mutant protein activates c-Ahl tyrosine kinase in response to ionizing radiation. Nature 387, 516-9.
4. Beatty, D. W., Arens, L. J., and Nelson, M. M. (19S6). Ataxia-telangiectasia. X,14 translocation, progressive deterioration of lymphocyte numbers and function, and abnormal in vitro immunoglobulin production. S. Afr. Mcd. J. 69, 115-118.
5. Blunt, T., Finnic, N. J., Taccioli, G. E., Smith, G. C., Demengeot, J., Gottlieb, T. M., Mizuta, R., Varghese, A. J., Alt, F. W., Jeggo, P. A., et al. (1995). Defective DNAdependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine seid mutation. Cell 80, 813-823.
6. Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Shin, T. B., and Schreiber, S. L. (1995). Control of p70 s6 kinase by kinase activity of FRAP in-civo. Nature 377, 441-446.
7. Canman, C. E., Chen, C. Y., Lee, M. II., and Kastan, M. B. (1994). DNA damage responses: p53 induction, cell cycle perturbations, and apoptosis. CSH Symp. Quant. Biol. 59, 277-286.
8. Cohen, M. M., and Levy, H. P. (1989). Chromosome instability syndromes. Adv. Human Genet. 18, 43-149.
9. Comforth, M. N., and Bedford, J. S. (19S5). On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science 227, 1589-1591.
10. Elson, A., Wang, Y., Daugherty, C. J., Morton, C. C., Zhou, F., Campos-Torres, J., and Leder, P. (1996). Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl. Acad. Sei. U.S.A. 93, 13084-130S9.
11. Giaccia, A., Weinstein, R., Hu, J., and Stamato, T. D. (1985). Cell cycle-dependent repair of double-strand DNA breaks in a gamma-ray-sensitive Chinese hamster cell. Somat. Cell. Mol. Genet. 11, 485-491.
12. Grcemvell, P. W., Kronmal, S. L., Porter, S. E., Gassenhuber, J., Obennaier, B., and Petes, T. D. (1995). TEL1, a gene involved in controlling telomere length in S. ccrccisiae, is homologous to the human ataxia telangiectasia gene. Cell 82, 823-829.
13. Hartley, K. O!, Gell, D., Smith, G. C., Zhang, IL, Divecha, N., Connelly, M. A., Admon, A., Lees-Miller, S. P., Anderson, C. W., and Jackson, S. P. (1995). DNA-dependent protein kinase catalytic subunit: A relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 82, 849-856.
14. Hecht, F., and Hecht, B. K. (19S7). Chromosome changes connect immunodeficiency and cancer in ataxia-telangiectasia. Am. J. Pecliatr. Hcmatol. Oncol. 9, 185-188.
15. Hecht, F., McCaw, B. K., and Koler, R. D. (1973). Ataxia-telangiectasia-Clonal growth of translocation lymphocytes. N. EngJ. J. Med. 289, 286-291.
16. Hsieh, C. L., Arlett, C. F., and Lieber, M. R. (1993). V(D)J recombination in ataxia telangiectasia, Bloom's syndrome, and a DNA ligase I-associated immunodeficiency disorder. J. biol. Chem. 268, 20105-20109.
17. Jayaraman, L., Murthy, K. G., Zhu, C., Curran, T., Xanthoudakis, S., and Prives, C. (1997). Identification of redox/repair protein Ref-1 äs a potent activator of p53. Genes Dcv. 11, 558-570.
18. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71,587-597.
19. Khanna, K. K., and Lavin, M. F. (1993). Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogenc 8, 3307-3312.
20. Khanna, K. K., Yan, J., Watters, D., Hobson, K., Beamish, IL, Spring, K., Shiloh, Y., Gatti, R. A., and Lavin, M. F. (1997). Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed ataxia-telangiectasia cells.J. biol. Clicm. 272,9489-9495.
21. Kojis, T. L., Gatti, R. A., and Sparkes, R. S. (1991). The cytogenetics of ataxia telangiectasia. Cancer Genet. Cijtogcnet. 56, 143-156.
22. Lehmann, A. R. (19S2). "Ataxia-Telangiectasia: A Cellular and Molecular Link between Cancer, Neuropathology and Immune Deficiency" (B. A. Bridges and D. G. Hamden, eds.), pp. 83-102. Wiley, New York.
23. Levis, W. R., Dattner, A. M., and Shaw, J. S. (1979). Selective defects in T cell function in ataxia-telangiectasia. Clin. Exp. Immnnol. 37, 44-49.
24. Li, Z., Otevrel, T., Gao, Y., Cheng, IL L., Seed, B., Stamato, T. D., Taccioli, G. E., and Alt, F. W. (1995). The XRCC4 gene encodes a novel protein involved in DNA doublestrand break repair and V(D)J recombination. Cell 83, 1079-1089.
25. Liao, M. J., Zhang, X. X., Hill, R., Gao,.J., Qumsiyeh, M. B., Nichols, W., and Van Dyke, T. (1998). No requirement for V(D)J recombination in p53-deficient thymic lymphoma. A/oJ. Cell. Biol. 18, 3495-3501.
26. Lin, W. C., and Desiderio, S. (1995). V(D)J recombination and the cell cycle. Immnnol. Today 16, 279-289.
27. Malynn, B. A., Blackwell, T. K., Fulop, G. M., Rathbun, G. A., Furley, A. J., Ferner, P., Heinke, L. B., Phillips, R. A., Yancopoulos, G. D., and Alt, F. W. (1988). The seid defect affects the final step of the immunoglobulin VDJ recombinase mechanism. Cell 54, 453-460.
28. Metcalfe, J. A., Parkhill, J., Campbell, L., Stacey, M., Biggs, P., Byrd, P. J., and Taylor, A. M. (1996). Accelerated telomere shortening in ataxia telangiectasia. Nature Genet. 13, 350-353.
29. Meyn, M. S. (1995). Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res. 55, 5991-6001.
30. Mombaerts, P., Clarke, A. R., Rudnicki, M. A., lacomini, J., Itohara, S., Lafaille, J. J., Wang, L., Ichikawa, Y., Jaenisch, R., Hooper, M. L., et al. (1992). Mutations in T-cell antigen receptor genes alpha and beta block tlrymocyte development at different stages. Nature 360, 225-331.
31. Morrell, D., Cromartie, E., and Swift, M. (1986). Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J. Natl. Cancer Inst. 77, 89-92. , Morrow, D. M., Tagle, D. A., Shiloh, Y., Collins, F. S., and Hieter, P. (1995). TEL1, an S. ccrevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1. Cell 82, 831-840.
32. Nacht, M., and Jacks, T. (1998). V(D)J recombination is not required for the development of lymphoma in p53-deficient mice. Cell Growth Differ. 9, 131-138.
33. N'arducci, M. G., Virgilio, L., Isobe, M., Stoppacciaro, A., Elli, R., Fiorilli, M., Carbonari, M., Antonelli, A., Chessa, L., Croce, C. M., et al. (1995). TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. Blood 86, 2358-2364.
34. Oxford, J. M., Hamden, D. G., Parrington, J. M., and Delhanty, J. D. (1975). Specific chromosome aberrations in ataxia telangiectasia. J. Mcd. Genet. 12, 251-262.
35. Paganelli, R., Capobianchi, M. R., Matricardi, P. M., Cioe, L., Seminara, R., Dianzani, F., and Aiuti, F. (1984). Defective interferon-gamma production in ataxia-telangiectasia. Clin. Immunol. Immunopalhol. 32, 387-391.
36. Painter, R. B., and Young, B. R. (1980). Radiosensitivity in ataxia-telangiectasia: A new explanation. Proc. Natl. Acad. Sei. U.S.A. 77, 7315-7317.
37. Paulovich, A. G., and Hartwell, L. H. (1995). A checkpoint regulates the rate of progression through S phase in S. ccrcvisiae in response to DNA damage. Cell 82, 841-847.
38. Paulovich, A. G., Toczyski, D. P., and Hartwell, L. H. (1997). When checkpoints fail. Cell 88, 315-321.
39. Peterson, R. D., and Funkhouser, J. D. (19S9). Speculations on ataxia-telangiectasia: Defec-tive regulation of the immunoglobulin gene superfamily. Immunol. Today 10, 313-314.
40. Peterson, R. D. A., and Good, R. A. (1968). Ataxia-telangiectasia. In "Birth Defects -Immunologic Deficiency Diseases in Man" (D. Bergsma and R. A. Good), pp. 370-377.
41. National Foundation, March of Dimes, New York, New York.
42. Savitsky, T. K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995). A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749-1753.
43. Schatz, D. G. (1997). V(D)J recombination moves in vitro. Semin. Immunol. 9, 149-159.
44. Schlissel, M., Constantinescu, A., Morrow, T., Baxter, M., and Peng, A. (1993). Double-strand signal sequence breaks in V(D)J recombination are blunt, 5'-phosphorylated, RAG-dependent, and cell cycle regulated. Genes Dcv. 7, 2520-2532.
45. Shiloh, Y. (1995). Ataxia-telangiectasia: Closer to unraveling the mystery. Eur. J. Human Genet. 3, 116-138.
46. Shinkai, Y., Rathbun, G., Lam, K. P., Oltz, E. M., Stewart, V., Mendelsohn, M., Charron, J., Datta, M., Young, F., Stall, A. M., et al. (1992). RAG-2-deficient mice, lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855-867.
47. Shinkai, Y., Koyasu, S., Nakayama, K., Murphy, K. M., Loh, D. Y., Reinherz, E. L., and Alt, F. W. (1993). Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes. Science 259, 822-825.
48. Stern, M. H., Theodorou, I., Aurias, A., Maier-Redelsperger, M., Debre, M., Debre, P., and Griscelli, C. (1989). T-Cell nonmalignant clonal proliferation in ataxia telangiectasia: A cytological, immunological, and molecular characterization. Blood 73, 1285-1290.
49. Strober, W., Wochner, R. D., Barlow, M. H., McFarlin, D. E. and Waldmann, T. A. (1968). Immunoglobulin metabolism in ataxia telangiectasia. J. Clin. Invest. 47, 1905-1915.
50. Tamura, T., Chiba, S., Abo, W., Chiba, Y., and Nakao, T. (1980). Cytomegalovirus-specific lymphocyte transformations in subjects of different ages with primary immunodeficiency. Infect. Immun. 28, 49-53.
51. Taylor, A. M.,'Metcalfe, J. A., Thick, J., and Mak, Y. F. (1996). Leukemia and lymphoma in ataxia telangiectasia. Blood 87, 423-438.
52. von Boehmer, H. (1994). Positive selection of lymphocytes. Cell 76, 219-228.
53. Westphal, C. H., Rowan, S., Schmaltz, C., Elson, A., Fisher, D. E., and Leder, P. (1997). atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nature Genet. 16, 397-401.
54. Woo, R. A., McLure, K. G., Lees-Miller, S. P., Rancourt, D. E., and Lee, P. W. (1998). DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature 394, 700-704.
55. Xu, Y., and Baltimore, D. (1996). Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev. 10, 2401-2410.
56. Xu, Y., Yang, E. M., Brugarolas, J., Jacks, T., and Baltimore, D. (1998). Involvement of p53 and p21 in cellular defects and tumorigenesis in atm-/- mice. Mol. Cell. Biol. 18, 4385-4390.
57. Xu, Y., Ashley, T., Brainerd, E. E., Bronson, R. T., Meyn, M. S., and Baltimore, D. (1996). Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10, 2411-2422.
58. Zakian, V. A. (1995). ATM-related genes: What do they tell us about functions of the human gene? Cell 82, 685-687.